Lonza has selected IDBS’s Bioprocess Execution System as an electronic data management and execution solution for mammalian cell culture process development. The system is intended to optimize the management of process development data and drive operational excellence to Lonza customers.

“We believe that adopting IDBS’s Bioprocess Execution System as our data management solution will help us improve our processes and enhance the quality of the services we provide to customers,” said Dr. Steve Flatman, Lonza’s head of Mammalian Development Services.

Data management systems like this one enable companies to integrate and optimize bioprocess workflows, capturing high-value data previously locked in paper records or isolated electronic files, across multiple locations and in different formats.

Generating complete laboratory-to-report lifecyles within one system, and making data retrievable by scientists to help in targeting process optimizations, will assist the drive for operational excellence, a core part of Lonza’s strategy.

“IDBS continues to develop informatics solutions that address the critical business needs of high value R&D and manufacturing activities,” said Neil Kipling, founder and chief executive officer of IDBS. “We believe that the bioprocess sector is an area of considerable growth and will benefit from our broad expertise and industry experience. We are delighted to be working with such an innovative company as Lonza, one of the first contract manufacturers to adopt our approach to process and knowledge management.”